Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins
about
Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation productsFormation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3Mechanism of action of factor D of the alternative complement pathwayTranslational mini-review series on complement factor H: genetics and disease associations of human complement factor H.Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.Complement control protein factor H: the good, the bad, and the inadequate.Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosisBiological effects of short-term, high-concentration exposure to methyl isocyanate. VI. In vitro and in vivo complement activation studies.Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levelsBactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B StreptococcusRelease of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulinExpression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragmentsOpsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.Antibody-independent activation of the alternative complement pathway by measles virus-infected cellsInduction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide.Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.The role of the complement system in acute kidney injury.Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA).Properdin Levels in Individuals with Chemotherapy-Induced Neutropenia.C3b and factor H: key components of the complement system.Inhibition of zymosan-induced alternative complement pathway activation by concanavalin A.Defective bactericidal reaction by the alternative pathway of complement in atopic patients.Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b.Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.Solubilization of immune precipitates by six isolated alternative pathway proteins.Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
P2860
Q28578637-BFE2DCE6-AB7B-4392-B0E3-216688B264ACQ28610971-CD81A400-9326-487A-820E-D86D74007C08Q28610996-5FEF223A-A62D-427E-ADDC-4C807B1BC0ABQ28611019-3D7CE4FE-BDC4-4F26-A862-AC41E6F6A7E1Q33377799-324511D8-EE68-45C5-93C9-0E85A3729614Q33675896-ADD7A383-D697-4ECF-B50B-8592C3BC4733Q33765773-16AD46C5-273C-4859-8CDD-73AD38CD931BQ34067107-04803AB3-10EB-4EAA-B9B3-51047F8965E8Q34099154-258BFB13-287F-4CB1-85A5-BEC873659EF1Q34651178-0140D5D7-EFE5-4B1D-8A92-7DB69DE60C80Q34661020-4E342D56-9DEB-4F1A-8883-FDC9623DADD9Q35133241-EA26B81B-203A-4139-A0CE-E9A1458C6CEFQ36341359-FFA83F73-C7CE-4D02-AA3C-359920344927Q36343590-5F041B51-D934-4161-805A-274266AFC87FQ36344262-4D13E1A6-18C8-4C53-B4E9-D8E4D2216FC0Q36347899-BA2B6055-7142-426F-801B-D4177A9FD6FDQ36352460-D72B5C1B-8F35-4150-95F3-6199531DF80FQ36353461-E76913EA-0E43-4C5B-9167-064D4006BAE1Q36384230-7888FA37-4158-4D65-977E-77FD23E4F416Q36401494-6CB7AA25-7CA4-4F80-9A75-8A1D4DE789B7Q36426487-03B81C94-1DC5-4CEE-BD8C-90DF71ABA7CEQ36463266-B308C7E1-44A2-46D2-9445-6D806FC94F79Q36987928-CB769A2C-7FE5-4873-81C0-3437E6C4C88DQ36993336-7EBB9FC9-064D-454A-BD0B-8CCF8D3F744CQ37161587-F363F26F-8DBF-497C-AE1E-8334F0EBA7DDQ37275159-0ABEED5C-9129-4105-BB22-AC690A8FF87DQ37596659-49C94FC3-DB44-446E-A7EB-7C6A9FBEBCA8Q39012599-E5490D0E-B901-46B4-B967-48C3332A54A9Q40222861-8538631C-1B04-4A03-ADFA-9740589219A2Q40292881-462991EF-3B6F-4C81-B5F4-EABF16BFBCF4Q40599517-E709DD5E-F5B5-479A-9A5E-77A86ABDD9BCQ40611674-0997D029-F844-4FCF-9370-FEDCAA4D185DQ40830914-86E48D46-1F2E-4918-AB73-807947722C9AQ41690090-54FD1015-2A3E-4934-980B-A78E728E788FQ41837139-99504E7F-47B4-405A-80D6-A34F06FA09B6Q41967087-D34946C7-EA0B-4DC9-A853-51B65CAA7817Q41981035-89431AD4-C1E8-47E2-B336-E333FD6BBCA0Q42056441-BC08C3A2-367E-4A05-AEE3-B25B8BC9B80DQ42112065-BA5A4D31-3186-4FD8-BF99-9EE589A6A91BQ42242306-313ECE64-BD8B-415D-899A-8131987963CF
P2860
Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins
description
1978 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1978
@ast
im August 1978 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1978/08/01)
@sk
vědecký článek publikovaný v roce 1978
@cs
wetenschappelijk artikel (gepubliceerd op 1978/08/01)
@nl
наукова стаття, опублікована в серпні 1978
@uk
name
Initiation of the alternative ...... way from six isolated proteins
@ast
Initiation of the alternative ...... way from six isolated proteins
@en
Initiation of the alternative ...... way from six isolated proteins
@nl
type
label
Initiation of the alternative ...... way from six isolated proteins
@ast
Initiation of the alternative ...... way from six isolated proteins
@en
Initiation of the alternative ...... way from six isolated proteins
@nl
prefLabel
Initiation of the alternative ...... way from six isolated proteins
@ast
Initiation of the alternative ...... way from six isolated proteins
@en
Initiation of the alternative ...... way from six isolated proteins
@nl
P2093
P2860
P356
P1476
Initiation of the alternative ...... way from six isolated proteins
@en
P2093
H. J. Müller-Eberhard
M. K. Pangburn
P. H. Lesavre
R. D. Schreiber
P2860
P304
P356
10.1073/PNAS.75.8.3948
P407
P577
1978-08-01T00:00:00Z